The PGspot - The Pink Pill Paradox: Sex, Science, and Double Standards

When it comes to sexual health treatments, why have men historically had more options than women? In this episode of The PG Spot, Dr. Patty Jalomo explores the fascinating and controversial journey of Addyi (flibanserin), the first FDA-approved medication for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. We'll dive into the years-long approval process, the advocacy movement that challenged the FDA, and the debates surrounding safety, efficacy, and gend...